PETER HENDRICKS: Open Payments
NPI 1528752706 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$944 in 29 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $840 · 2025 $944
Food & beverage: $944
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 5 | $241 |
| Abbott Laboratories | 1 | $175 |
| CVRx, Inc. | 1 | $138 |
| AstraZeneca Pharmaceuticals LP | 7 | $114 |
| E.R. Squibb & Sons, L.L.C. | 5 | $90 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| BridgeBio Pharma, Inc. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Amgen Inc. | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: AMVUTTRA, CARDIOMEMS, Barostim Neo System, WAINUA, ELIQUIS, Kerendia, Attruby, CAMZYOS.
Industry payments across CO — which companies pay providers there.
